15880601

Source:http://linkedlifedata.com/resource/pubmed/id/15880601

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003864, umls-concept:C0021467, umls-concept:C0021469, umls-concept:C0026336, umls-concept:C0026339, umls-concept:C0034693, umls-concept:C0034721, umls-concept:C0087111, umls-concept:C0442796, umls-concept:C1280500, umls-concept:C1367028, umls-concept:C1456820, umls-concept:C2699427
pubmed:issue	5
pubmed:dateCreated	2005-5-11
pubmed:abstractText	To investigate whether the bone-preserving effects of a RANKL antagonist or a tumor necrosis factor (TNF) antagonist could be further improved by the addition of a bone anabolic agent in inflammatory arthritis.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0370605
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Osteoprotegerin, http://linkedlifedata.com/resource/pubmed/chemical/PEGylated tumor necrosis factor..., http://linkedlifedata.com/resource/pubmed/chemical/Parathyroid Hormone, http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols, http://linkedlifedata.com/resource/pubmed/chemical/RANK Ligand, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cytoplasmic and Nuclear, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor..., http://linkedlifedata.com/resource/pubmed/chemical/Tnfrsf11b protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0004-3591
pubmed:author	pubmed-author:BolonBradB, pubmed-author:BrownHeatherH, pubmed-author:FeigeUlrichU, pubmed-author:KostenuikPaulP, pubmed-author:LiZhuZ, pubmed-author:MiddletonScotS, pubmed-author:PretoriusJimJ, pubmed-author:SchettGeorgG, pubmed-author:StolinaMarinaM, pubmed-author:ZackDebra JDJ
pubmed:issnType	Print
pubmed:volume	52
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1604-11
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:15880601-Animals, pubmed-meshheading:15880601-Arthritis, pubmed-meshheading:15880601-Bone Development, pubmed-meshheading:15880601-Bone Diseases, pubmed-meshheading:15880601-Bone Resorption, pubmed-meshheading:15880601-Carrier Proteins, pubmed-meshheading:15880601-Cell Count, pubmed-meshheading:15880601-Disease Models, Animal, pubmed-meshheading:15880601-Drug Synergism, pubmed-meshheading:15880601-Female, pubmed-meshheading:15880601-Glycoproteins, pubmed-meshheading:15880601-Male, pubmed-meshheading:15880601-Membrane Glycoproteins, pubmed-meshheading:15880601-Osteoblasts, pubmed-meshheading:15880601-Osteoprotegerin, pubmed-meshheading:15880601-Parathyroid Hormone, pubmed-meshheading:15880601-Polyethylene Glycols, pubmed-meshheading:15880601-RANK Ligand, pubmed-meshheading:15880601-Rats, pubmed-meshheading:15880601-Rats, Inbred Lew, pubmed-meshheading:15880601-Receptors, Cytoplasmic and Nuclear, pubmed-meshheading:15880601-Receptors, Tumor Necrosis Factor, pubmed-meshheading:15880601-Receptors, Tumor Necrosis Factor, Type I, pubmed-meshheading:15880601-Tumor Necrosis Factor-alpha
pubmed:year	2005
pubmed:articleTitle	Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models.
pubmed:affiliation	Amgen Inc., Thousand Oaks, California, and Medical University of Vienna, Vienna, Austria.
pubmed:publicationType	Journal Article